The link between human papillomavirus (HPV) infection and the development of pre-cancerous cervical lesions and cervical cancer is well known.1 High risk HPV types 16 and 18 account for 70% of cervical cancers and precancerous cervical lesions.2 The HPV test can be utilised as an effective instrument for diagnosing cervical cancer. Detection of HPV infection at an early enough stage can enhance the 5-year survival rate to about 93%.3 The 'Don't Just Sit There' campaign was initiated across several states in Australia with the aim to improve the screening rate of cervical cancer. As a result, the number of Pap tests conducted during the campaign increased by 21% within a year.